Stocktoria
Evotec SE EVT.DE
DE · Deutsche Börse Xetra · XETR · stock · Healthcare · website
Evotec SE statistics & valuation
Market cap€904.8M
P / S1.1×
P / B1.1×
Net margin-13.1%
Return on equity-12.7%
FCF margin-11.6%
Net debt€45.9M
Enterprise value USD$1.1B
Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 14.5% | 14.4% | 22.4% | 23.2% |
| Operating margin | -7.1% | -9.9% | -3.4% | 2.8% |
| Net margin | -13.1% | -24.6% | -10.7% | -23.4% |
| FCF margin | -11.6% | -14.3% | -23.0% | 3.3% |
| Return on assets | -6.0% | -10.3% | -3.7% | -7.8% |
| Return on equity | -12.7% | -20.6% | -7.5% | -14.8% |
| Debt / equity | 0.42× | 0.41× | 0.43× | 0.28× |
| Current ratio | 2.07 | 1.98 | 1.94 | 3.18 |
Computed from company filings · DE · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.